Registered Trials
-
NCT04830800
Phase 1/2Viet Nam
Total Enrollment: 420
Official Trial Registration:
-
NCT05046548
Phase 1/2Russian Federation
Total Enrollment: 400
Official Trial Registration:
Vaccine Type: Non Replicating Viral Vector
This vaccine has reached Phase 2 trials.
There are no trials for this phase.
This vaccine is not yet approved.
Viet Nam
Total Enrollment: 420
Russian Federation
Total Enrollment: 400
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.